The Global Alliance for TB Drug Development (TB Alliance) and Rutgers, The State University of New Jersey announced a collaboration
The Global Alliance for TB Drug Development (TB Alliance) and sanofi-aventis announced today that they have entered into a collaboration
The Global Alliance for TB Drug Development (TB Alliance), a public-private product-development partnership leading the development of new and affordable
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) announced today a
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
LONDON, UK and NEW YORK, January 24, 2008 – GlaxoSmithKline (GSK) and the Global Alliance for TB Drug Development (TB
NEW YORK & CAPE TOWN, South Africa–The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of
